CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 12 enrolled
Drug / intervention
Memory and Adaptation Training-Geriatricsbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05258058
NCT05258058N/ACompleted

Mitigating Cancer-Related Cognitive Impairment in Older Adults With Cancer: Memory and Attention Adaptation Training-Geriatrics (MAAT-G) Phase I

Allison Magnuson·interventional·Posted Feb 28, 2022·Updated Jul 10, 2024

In Brief

A clinical study evaluating Memory and Adaptation Training-Geriatrics for Cognitive Dysfunction. Completed, enrolled 12 participants across 1 site.

Detailed Summary

Cancer-related cognitive dysfunction (CRCD) affects up to 75% of patients receiving chemotherapy and older adults are at greater risk of developing CRCD, which can negatively affect their functional independence and quality of life. Memory and Attention Adaptation Training-Geriatrics (MAAT-G) is a cognitive behavioral therapy-based intervention tailored specifically for older adults and the feasibility of MAAT-G in older cancer survivors with Mild Cognitive Impairment (MCI) is being evaluated.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
20222023202420252026
First PostedFeb 28, 2022
Enrollment StartDec 10, 2021
Primary CompletionJul 20, 2023
Study CompletionJul 26, 2023
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 4.3 years ago

Interventions

Memory and Adaptation Training-Geriatricsbehavioral

MAAT-G is a cognitive behavioral therapy-based intervention comprised of 10 workshop sessions as well as a participant workbook. The workshop sessions are delivered one on one by a health professional via videoconferencing technology.